Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Chang Chiang

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Clinical and Translational Science|March 4, 2026
Evaluation of the Effect of Food and Formulation on the Pharmacokinetics of the SHP2 Inhibitor Migoprotafib Within a Phase I Study in Cancer PatientsJulia Suchomel, Christine M Bowman, Po-Chang Chiang, et al.
International Journal of Pharmaceutics|February 3, 2024
Development of an extemporaneous preparation formulation using a simple and non-solubilizing matrix for first in human clinical studyCheng W Chiang, Shijia Tang, Jasper Martijn Boonstra, et al.
Drug Metabolism Letters|October 22, 2013
Inhibition of hepatobiliary transporters by a novel kinase inhibitor contributes to hepatotoxicity in beagle dogsJohn Scott Daniels, Yurong Lai, Sarah South, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 27, 2009
A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal modelsGabriel Mbalaviele, Cynthia D Sommers, Sheri L Bonar, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Automated Radiology Alert System for Pneumothorax Detection on Chest Radiographs Improves Efficiency and Diagnostic PerformanceCheng-Yi Kao, Chiao-Yun Lin, Cheng-Chen Chao, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 30, 2009
Novel tight-binding inhibitory factor-kappaB kinase (IKK-2) inhibitors demonstrate target-specific anti-inflammatory activities in cellular assays and following oral and local delivery in an in vivo model of airway inflammationCynthia D Sommers, Janice M Thompson, Julia A Guzova, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2023
Filling a nick in NIK: Extending the half-life of a NIK inhibitor through structure-based drug designJames J Crawford, Jianwen Feng, Hans D Brightbill, et al.
Journal of Medicinal Chemistry|February 5, 2019
Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple MyelomaXiaojing Wang, Wesley Blackaby, Vivienne Allen, et al.
Journal of Medicinal Chemistry|June 26, 2018
Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing KinaseNicole Blaquiere, Georgette M Castanedo, Jason D Burch, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Clinical and Translational Science|March 4, 2026
Evaluation of the Effect of Food and Formulation on the Pharmacokinetics of the SHP2 Inhibitor Migoprotafib Within a Phase I Study in Cancer PatientsJulia Suchomel, Christine M Bowman, Po-Chang Chiang, et al.
International Journal of Pharmaceutics|February 3, 2024
Development of an extemporaneous preparation formulation using a simple and non-solubilizing matrix for first in human clinical studyCheng W Chiang, Shijia Tang, Jasper Martijn Boonstra, et al.
Drug Metabolism Letters|October 22, 2013
Inhibition of hepatobiliary transporters by a novel kinase inhibitor contributes to hepatotoxicity in beagle dogsJohn Scott Daniels, Yurong Lai, Sarah South, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 27, 2009
A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal modelsGabriel Mbalaviele, Cynthia D Sommers, Sheri L Bonar, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Automated Radiology Alert System for Pneumothorax Detection on Chest Radiographs Improves Efficiency and Diagnostic PerformanceCheng-Yi Kao, Chiao-Yun Lin, Cheng-Chen Chao, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 30, 2009
Novel tight-binding inhibitory factor-kappaB kinase (IKK-2) inhibitors demonstrate target-specific anti-inflammatory activities in cellular assays and following oral and local delivery in an in vivo model of airway inflammationCynthia D Sommers, Janice M Thompson, Julia A Guzova, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2023
Filling a nick in NIK: Extending the half-life of a NIK inhibitor through structure-based drug designJames J Crawford, Jianwen Feng, Hans D Brightbill, et al.
Journal of Medicinal Chemistry|February 5, 2019
Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple MyelomaXiaojing Wang, Wesley Blackaby, Vivienne Allen, et al.
Journal of Medicinal Chemistry|June 26, 2018
Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing KinaseNicole Blaquiere, Georgette M Castanedo, Jason D Burch, et al.
Pageof 6